Future Directions of Intraperitoneal Chemotherapy

Please read this page completely before beginning the activity. If you have any questions or need further information, please call the Memorial Sloan Kettering Cancer Center's CME Office at 646-227-2025.
Future Directions of Intraperitoneal Chemotherapy

Carol Aghajanian provides participants with an overview comparison of current data between IV chemotherapy and IP chemotherapy for treatment of the ovarian cancer patient.

Course Information

Lecture Date
September 2009
Target Audience

This program is directed toward all physicians involved in the treatment of patients with ovarian cancer.

Educational Objectives

This activity will provide participants with an overview comparison of current data between IV Chemotherapy and IP Chemotherapy for treatment of the Ovarian cancer patient. The ultimate goal of the activity is to improve the care provided to ovarian cancer patients.